marketing Archives - World Asthma Foundation

December 3, 2015

GSK gets European marketing rights for Nucala to treat asthma – The Pharma Letter (registration)

GSK gets European marketing rights for Nucala to treat asthma
The Pharma Letter (registration)
UK drug major GlaxoSmithKline (LSE: GSK) said the European Commission has granted marketing rights for its drug Nucala (mepolizumab) as an add-on treatment for asthma. Nucala is now approved for use in the 31 European countries covered by the …
EU OK for GSK's novel asthma biologicPharmaTimes
Nucala Now Available for Severe AsthmaMonthly Prescribing Reference (registration)
EU Grants Marketing Authorization to GSK's NucalaDrug Discovery & Development
StreetInsider.com –The FINANCIAL –RTT News
all 18 news articles »

View full post on asthma – Google News

June 10, 2015

GSK asthma medication to go before FDA panel Thursday – Medical Marketing and Media

Medical Marketing and Media

GSK asthma medication to go before FDA panel Thursday
Medical Marketing and Media
GSK's struggle is tied to its blockbuster asthma drug Advair. The drugmaker not only had to lower the price of the branded medication before generic competition surfaced, but it has also failed to build a market for its successor line of Ellipta-based …

View full post on asthma – Google News

April 29, 2014

Teva’s DuoResp Spiromax receives EC marketing authorization for treatment of … – News-Medical.net

Teva's DuoResp Spiromax receives EC marketing authorization for treatment of …
News-Medical.net
Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) announced today that the European Commission has granted marketing authorization for DuoResp Spiromax® for the treatment of patients with asthma and chronic obstructive pulmonary disease (COPD) …
Teva Gets Approval To Market DuoResp Spiromax In EuropeRTT News

all 2 news articles »

View full post on asthma – Google News

January 8, 2014

Discontinued OTC asthma med may make comeback – Medical Marketing and Media

Discontinued OTC asthma med may make comeback
Medical Marketing and Media
OTC inhaler Primatene Mist officially left the building in August 2013, just over two years after it was banned because the prescription-free asthma inhaler's chlorofluorocarbons violated environmental regulations. Regulatory Focus reports that the …

View full post on asthma – Google News

August 22, 2013

Marketing campaign boosts older adult asthma awareness – medwireNews

Marketing campaign boosts older adult asthma awareness
medwireNews
medwireNews: Researchers in Australia report that a community-level social marketing campaign has been successful in raising asthma awareness among older adults. The campaign, called “Get Your Life Back,” resulted in increased visits to the doctor and …

View full post on asthma – Google News

July 5, 2012

Glaxo Tries to Shake Marketing Questions on Advair – Wall Street Journal

Wall Street Journal

Glaxo Tries to Shake Marketing Questions on Advair
Wall Street Journal
GlaxoSmithKline's $3 billion criminal and civil settlement with the U.S. government this week raises questions about the future of asthma treatment Advair.
Glaxo Executives Cited in Case Now Lead Sanofi, ActelionBusinessweek
WSJ: Glaxo Tries to Shake Marketing QuestionsNASDAQ
Ex-Glaxo execs in U.S. case now lead other drugmakersBend Bulletin
FiercePharma –NPR (blog)
all 46 news articles »

View full post on asthma – Google News

July 5, 2012

Glaxo Tries to Shake Marketing Questions – Wall Street Journal

The Guardian

Glaxo Tries to Shake Marketing Questions
Wall Street Journal
GlaxoSmithKline's $3 billion criminal and civil settlement with the U.S. government this week raises questions about the future of asthma treatment Advair.
Glaxo Executives Cited in Case Now Lead Sanofi, ActelionBusinessweek
WSJ: Glaxo Tries to Shake Marketing QuestionsNASDAQ
Ex-Glaxo execs in U.S. case now lead other drugmakersBend Bulletin
FiercePharma –NPR (blog)
all 46 news articles »

View full post on asthma – Google News

July 3, 2012

Glaxo Settlement Pulls Back Curtain On Drug Marketing – NPR (blog)

Glaxo Settlement Pulls Back Curtain On Drug Marketing
NPR (blog)
The government alleged that Glaxo promoted Advair, an asthma remedy combining two drugs, for use as a first-choice treatment for just about anybody with asthma. The Food and Drug Administration, concerned about risks, took a much narrower view and …

and more »

View full post on asthma – Google News

July 3, 2012

Glaxo Settlement Pull Back Curtain On Drug Marketing – NPR (blog)

Glaxo Settlement Pull Back Curtain On Drug Marketing
NPR (blog)
The government alleged that Glaxo promoted Advair, an asthma remedy combining two drugs, for use as a first-choice treatment for just about anybody with asthma. The Food and Drug Administration, concerned about risks, took a much narrower view and …

and more »

View full post on asthma – Google News

July 3, 2012

SkyePharma’s asthma drug gets European marketing nod – Reuters

SkyePharma's asthma drug gets European marketing nod
Reuters
Company sees launching drug across Europe in H2* Stock up 28 pct, top percentage gainer on LSEJuly 3 (Reuters) – Britain's SkyePharma Plc said itsasthma therapy Flutiform got marketing approval from.

and more »

View full post on asthma – Google News